Biocryst Sucks Customer Reviews and Feedback
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug RAPIVAB was approved by FDA in Dec 2014.
An employee mentioned, "Anxiety over the future. BioCryst as a small biotech, there is no funding and therefore an uncertain future. No promotions available although you can get experience."
Former Employee - Anonymous Employee says"Unstable financially. Prone to large Lay-offs about every 3-7 years since 1987"
says"Too many VPs and senior execs. Out of touch with the rest of the co."